Cargando…
Pembrolizumab- and ipilimumab-induced diabetic ketoacidosis and isolated adrenocorticotropic hormone deficiency: a case report
BACKGROUND: Several human monoclonal antibodies directed against immune checkpoints, including T lymphocyte antigen 4 and programmed cell death protein 1, have been implemented for cancer treatment in order to promote effector T cell response to tumors. Despite the antitumor activity of these agents...
Autores principales: | Porntharukchareon, Thachanun, Tontivuthikul, Borwonkhun, Sintawichai, Nattaya, Srichomkwun, Panudda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523376/ https://www.ncbi.nlm.nih.gov/pubmed/32988414 http://dx.doi.org/10.1186/s13256-020-02502-w |
Ejemplares similares
-
A Case of Isolated Adrenocorticotropic Hormone Deficiency Caused by Pembrolizumab
por: Bekki, Tomoaki, et al.
Publicado: (2020) -
SAT-242 Isolated Adrenocorticotropic Hormone Deficiency Secondary to the PD-1 Inhibitor Pembrolizumab
por: Mathew, Justin, et al.
Publicado: (2020) -
Pembrolizumab-Induced Hypophysitis With Isolated Adrenocorticotropic Hormone (ACTH) Deficiency: A Rare Immune-Mediated Adverse Event
por: Doodnauth, Andrew V, et al.
Publicado: (2021) -
Petrified Ear Auricles with Isolated Adrenocorticotropic Hormone Deficiency
por: Taguchi, Takafumi, et al.
Publicado: (2017) -
Isolated Adrenocorticotropic Hormone Deficiency Secondary to Chronic Opiate Use
por: Raj, Rishi, et al.
Publicado: (2020)